ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #13,145Hybrid

Behavioural Pharmacology

Acronym:bpharm
•
Abbreviation (ISO):Behav. Pharmacol
•
Identifier (ISSN):0955-8810(Print)/1473-5849(Online)
•
Publisher:Lippincott Williams and Wilkins Ltd.
Clarivate IF (2026)
1.4↓ -0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Behavioural Pharmacology

WoS Q4
01231.8520181.7920192.2920212.2820221.620231.620241.620251.42026
Annual Impact Factor Metric
Current (2026):1.4
Scopus SJR & RankScopus Q3
0.444
#13,145

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
92

92 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate6.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
63articles/year
3.36% Gold OA•86.27% Original Research

Aims & Scope

Behavioural Pharmacology accepts original full and short research reports in diverse areas ranging from ethopharmacology to the pharmacology of schedule-controlled operant behaviour, provided that their primary focus is behavioural. Suitable topics include drug, chemical and hormonal effects on behaviour, the neurochemical mechanisms under-lying behaviour, and behavioural methods for the study of drug action. Both animal and human studies are welcome; however, studies reporting neurochemical data should have a predominantly behavioural focus, and human studies should not consist exclusively of clinical trials or case reports. Preference is given to studies that demonstrate and develop the potential of behavioural methods, and to papers reporting findings of direct relevance to clinical problems. Papers making a significant theoretical contribution are particularly welcome and, where possible and merited, space is made available for authors to explore fully the theoretical implications of their findings. Reviews of an area of the literature or at an appropriate stage in the development of an author’s own work are welcome. Commentaries in areas of current interest are also considered for publication, as are Reviews and Commentaries in areas outside behavioural pharmacology, but of importance and interest to behavioural pharmacologists. Behavioural Pharmacology publishes frequent Special Issues on current hot topics. The editors welcome correspondence about whether a paper in preparation might be suitable for inclusion in a Special Issue.

Topics Covered (Recognized by AI)
Medicine94.3%Biology93.4%Psychology86.1%Internal medicine80.9%Neuroscience69.6%Chemistry68.7%Biochemistry62.9%Genetics58.5%Pharmacology58.5%Psychiatry56.2%Endocrinology55.7%Receptor52.3%Anesthesia27%Dopamine24.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BEHAVIORAL SCIENCES

Q4
Rank46/57
IndexSCIE
JCRSCIE2026

NEUROSCIENCES

Q4
Rank293/330
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank295/356
IndexSCIE
JCISCIE2026

BEHAVIORAL SCIENCES

Q4
Rank53/57
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q4
Rank269/330
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank244/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.4
Articles / Year30
Total Citations7
2025
IF1.6
Articles / Year58
Total Citations73
2024
IF1.6
Articles / Year48
Total Citations128
2023
IF1.6
Articles / Year47
Total Citations184
2022
IF2.277
Articles / Year48
Total Citations364

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #13,145Scopus Q3SCImago Profile
Scopus Coverage:1992-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.444

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.47

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,930 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations253
3-Year Documents146
Citable Documents145

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ3
Psychiatry and Mental HealthQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Psychology
Minor Category (Specific Field):
4区BEHAVIORAL SCIENCES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Behavioural Pharmacology (acronym: bpharm, abbr: Behav. Pharmacol, ISSN: 0955-8810) is a peer-reviewed international scholarly journal in the field of Medicine, published by Lippincott Williams and Wilkins Ltd. in United States since 1989. The periodical holds a Journal Impact Factor (JIF) of 1.40, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.444 (Q3), an H-index of 92.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 63 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,930 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
1989
Indexing & Databases
SCIEScopusPubMed
Editorial Address
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: dc45a82a-e83a-4966-8f47-438f59b463f1
Database Updated: 2026-09-29